Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gopala K Rangan

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Journal of the American Society of Nephrology : JASN|April 2, 2026
Treatment of Autosomal Dominant Polycystic Kidney Disease: Integrating Clinical Practice Guidelines, Patient Perspectives, and Real-World EffectivenessGopala K Rangan
Drug Safety|December 7, 2006
Sirolimus-associated proteinuria and renal dysfunctionGopala K Rangan
World Journal of Nephrology|May 7, 2016
C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuriaGopala K Rangan
Methods in Molecular Biology (Clifton, N.J.)|July 9, 2023
Culture of Three-Dimensional Madin-Darby Canine Kidney (MDCK) Cysts for In Vitro Drug Testing in Polycystic Kidney DiseaseSayanthooran Saravanabavan, Gopala K Rangan
International Journal of Molecular Sciences|October 27, 2022
Kidney Cyst Lining Epithelial Cells Are Resistant to Low-Dose Cisplatin-Induced DNA Damage in a Preclinical Model of Autosomal Dominant Polycystic Kidney DiseaseSayanthooran Saravanabavan, Gopala K Rangan
International Journal of Nephrology and Renovascular Disease|March 25, 2024
Advances in Human-Centered Care to Address Contemporary Unmet Needs in Chronic DialysisSumedh Jayanti, Gopala K Rangan
Nephrology (Carlton, Vic.)|July 31, 2021
Possible role of the mitochondrial genome in the pathogenesis of autosomal dominant polycystic kidney diseaseSayanthooran Saravanabavan, Gopala K Rangan
Kidney International Reports|October 18, 2023
Cardiovascular Manifestations and Management in ADPKDPriyanka S Sagar, Gopala K Rangan
Nephrology (Carlton, Vic.)|November 13, 2007
Quantification of renal pathology by image analysisGopala K Rangan, Greg H Tesch
Current Hypertension Reviews|August 27, 2013
Rationale and design of an observational study to determine the effects of cholecalciferol on hypertension, proteinuria and urinary MCP-1 in ADPKDGopala K Rangan, David C Harris
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Journal of the American Society of Nephrology : JASN|April 2, 2026
Treatment of Autosomal Dominant Polycystic Kidney Disease: Integrating Clinical Practice Guidelines, Patient Perspectives, and Real-World EffectivenessGopala K Rangan
Drug Safety|December 7, 2006
Sirolimus-associated proteinuria and renal dysfunctionGopala K Rangan
World Journal of Nephrology|May 7, 2016
C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuriaGopala K Rangan
Methods in Molecular Biology (Clifton, N.J.)|July 9, 2023
Culture of Three-Dimensional Madin-Darby Canine Kidney (MDCK) Cysts for In Vitro Drug Testing in Polycystic Kidney DiseaseSayanthooran Saravanabavan, Gopala K Rangan
International Journal of Molecular Sciences|October 27, 2022
Kidney Cyst Lining Epithelial Cells Are Resistant to Low-Dose Cisplatin-Induced DNA Damage in a Preclinical Model of Autosomal Dominant Polycystic Kidney DiseaseSayanthooran Saravanabavan, Gopala K Rangan
International Journal of Nephrology and Renovascular Disease|March 25, 2024
Advances in Human-Centered Care to Address Contemporary Unmet Needs in Chronic DialysisSumedh Jayanti, Gopala K Rangan
Nephrology (Carlton, Vic.)|July 31, 2021
Possible role of the mitochondrial genome in the pathogenesis of autosomal dominant polycystic kidney diseaseSayanthooran Saravanabavan, Gopala K Rangan
Kidney International Reports|October 18, 2023
Cardiovascular Manifestations and Management in ADPKDPriyanka S Sagar, Gopala K Rangan
Nephrology (Carlton, Vic.)|November 13, 2007
Quantification of renal pathology by image analysisGopala K Rangan, Greg H Tesch
Current Hypertension Reviews|August 27, 2013
Rationale and design of an observational study to determine the effects of cholecalciferol on hypertension, proteinuria and urinary MCP-1 in ADPKDGopala K Rangan, David C Harris
Pageof 7